News New Approach to Adoptive T-Cell Therapy Shows Promise for Boosting Immune Response in Ovarian Cancer
News Unique Clinical Trial at Roswell Park Explores Complement Inhibitor for Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer with Malignant Effusion